NCT04856943View on ClinicalTrials.gov

Effectiveness of Smartconsent in Improving Understanding of Informed Consent

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Benign Prostatic Hyperplasia
Interventions
PROCEDURE

Smartconsent application

Patients asigned to smartconsent group will sign informed consent through a Tablet.

OTHER

Control group

Patient asigned to control group will sing the informed consent in papel, as it is performed in clinical practice

Trial Locations (2)

01003

Imanol Merino, Vitoria-Gasteiz

01009

Bioaraba Health Research Institute, Vitoria-Gasteiz

Sponsors
All Listed Sponsors
lead

Bioaraba Health Research Institute

NETWORK